Vident Investment Advisory’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-16,509
Closed -$1.18M 101
2023
Q2
$1.18M Buy
16,509
+4,146
+34% +$297K 0.04% 436
2023
Q1
$858K Buy
12,363
+3,055
+33% +$212K 0.03% 572
2022
Q4
$631K Sell
9,308
-7,328
-44% -$497K 0.02% 634
2022
Q3
$607K Buy
16,636
+384
+2% +$14K 0.02% 730
2022
Q2
$1.07M Sell
16,252
-5,233
-24% -$345K 0.03% 597
2022
Q1
$1.43M Buy
21,485
+3,863
+22% +$256K 0.04% 573
2021
Q4
$1.03M Sell
17,622
-11,485
-39% -$669K 0.03% 695
2021
Q3
$1.75M Buy
29,107
+2,566
+10% +$154K 0.05% 493
2021
Q2
$1.59M Sell
26,541
-4,749
-15% -$285K 0.05% 496
2021
Q1
$1.56M Sell
31,290
-1,410
-4% -$70.1K 0.05% 481
2020
Q4
$1.64M Buy
32,700
+6,186
+23% +$309K 0.07% 366
2020
Q3
$1.45M Sell
26,514
-409
-2% -$22.4K 0.07% 377
2020
Q2
$1.42M Sell
26,923
-4,091
-13% -$216K 0.07% 345
2020
Q1
$1.39M Sell
31,014
-1,232
-4% -$55K 0.09% 290
2019
Q4
$1.61M Sell
32,246
-3,467
-10% -$173K 0.1% 315
2019
Q3
$1.59M Sell
35,713
-717
-2% -$32K 0.14% 104
2019
Q2
$1.5M Sell
36,430
-3,900
-10% -$161K 0.12% 120
2019
Q1
$1.63M Sell
40,330
-86
-0.2% -$3.48K 0.09% 324
2018
Q4
$1.54M Sell
40,416
-24,891
-38% -$945K 0.09% 316
2018
Q3
$2.58M Sell
65,307
-3,783
-5% -$150K 0.1% 277
2018
Q2
$2.43M Buy
69,090
+16,137
+30% +$567K 0.1% 285
2018
Q1
$1.89M Buy
52,953
+15,448
+41% +$551K 0.08% 316
2017
Q4
$1.3M Buy
37,505
+3,522
+10% +$122K 0.06% 334
2017
Q3
$1.15M Buy
33,983
+1,029
+3% +$34.9K 0.06% 348
2017
Q2
$1.12M Sell
32,954
-32
-0.1% -$1.09K 0.09% 311
2017
Q1
$1.03M Buy
32,986
+6,328
+24% +$197K 0.1% 307
2016
Q4
$728K Buy
26,658
+2,144
+9% +$58.6K 0.09% 308
2016
Q3
$806K Sell
24,514
-123
-0.5% -$4.04K 0.11% 307
2016
Q2
$744K Sell
24,637
-20,897
-46% -$631K 0.1% 300
2016
Q1
$1.28K Buy
45,534
+21,727
+91% +$612 0.08% 344
2015
Q4
$808K Buy
+23,807
New +$808K 0.1% 330